Disclosures for "Neurocognitive Manifestations of Individuals with NF1 Microdeletions")
-
Ms. Garzon has nothing to disclose.
-
Miss Patete has nothing to disclose.
-
Miss Serbinski has stock in Illumina.
-
Miss Hankins has nothing to disclose.
-
The institution of Dr. Sawin has received research support from National Institute of Neurological Disorders and Stroke (NINDS).
-
Ms. Goetsch Weisman has nothing to disclose.
-
Ms. Kim has nothing to disclose.
-
Dr. Charrow has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Charrow has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
-
Dr. Listernick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstroZeneca. Dr. Listernick has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for White and Williams.
-
Dr. Prada has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme Sanofi . Dr. Prada has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Prada has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Prada has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for America Journal of Medical Genetics. The institution of Dr. Prada has received research support from National Institute of Neurological Diseases and Stroke (NINDS). The institution of Dr. Prada has received research support from Department of Defense (DOD).